<Suppliers Price>

7-Bromo-1-heptene

Names

[ CAS No. ]:
4117-09-3

[ Name ]:
7-Bromo-1-heptene

[Synonym ]:
7-Bromo-1-Heptene
MFCD01631137
7-bromohept-1-ene

Chemical & Physical Properties

[ Density]:
1.162 g/mL at 25 °C(lit.)

[ Boiling Point ]:
27 °C1 mm Hg(lit.)

[ Melting Point ]:
0°C

[ Molecular Formula ]:
C7H13Br

[ Molecular Weight ]:
177.08200

[ Flash Point ]:
137 °F

[ Exact Mass ]:
176.02000

[ LogP ]:
3.12770

[ Index of Refraction ]:
n20/D 1.466(lit.)

[ Storage condition ]:
2~8℃

MSDS

Safety Information

[ Symbol ]:

GHS02, GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H226-H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
UN 1993 3/PG 3

[ WGK Germany ]:
3

[ HS Code ]:
2903399090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2903399090

[ Summary ]:
2903399090. brominated,fluorinated or iodinated derivatives of acyclic hydrocarbons. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0%

Articles

Synthesis of a metabolically stable modified long-chain fatty acid salt and its photolabile derivative.

J. Lipid Res. 32(5) , 843-57, (1991)

An analogue of the long-chain fatty acid salt, sodium stearate, was synthesized in which the hydrogen atoms at carbons 2, 3, and 18 were replaced by fluorine. The key step in the synthesis was the add...

Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress.

ChemMedChem 4(7) , 1095-105, (2009)

A series of benzolactam compounds were synthesized, some of which caused a concentration-dependent increase in sAPPalpha and decrease in Abeta production in the concentration range of 0.1-10 microM. M...

Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.

Bioorg. Med. Chem. 16(1) , 437-45, (2008)

Inhibitors of histone deacetylases (HDACs) are a promising class of anticancer agents that effect gene regulation. To know the interaction of aliphatic cap groups with HDACs, cyclic tetrapeptide and b...


More Articles


Related Compounds